Attending the #AACR26 Clinical Plenary on New Frontiers in Precision Oncology? ICYMI: D3S-001 Shows Robust Preclinical and Clinical Activity
https://
doi.org/10.1158/2159-8
290.CD-24-0006
…
By session speaker Byoung Chul Cho
@cbcbc1971
and colleagues